Obesity Hypoventilation Syndrome

Overview


Plain-Language Overview

Obesity Hypoventilation Syndrome is a condition that affects breathing in people who are significantly overweight. It involves the lungs and the body's ability to get rid of carbon dioxide and take in oxygen properly. People with this condition breathe too shallowly or slowly during sleep and sometimes even when awake, leading to low oxygen levels and high carbon dioxide levels in the blood. This can cause symptoms like daytime sleepiness, headaches, and difficulty concentrating. The extra weight on the chest and abdomen makes it harder for the lungs to expand fully, which worsens breathing problems. Over time, this can strain the heart and lead to serious health issues. Managing this condition is important to improve breathing and overall health.

Clinical Definition

Obesity Hypoventilation Syndrome (OHS) is defined by chronic daytime hypercapnia (arterial CO2 >45 mmHg) in obese individuals (BMI >30 kg/m2) without other causes of hypoventilation. The core pathology is alveolar hypoventilation due to impaired respiratory mechanics from excess adipose tissue, leading to reduced chest wall compliance and increased work of breathing. This results in chronic hypoxemia and hypercapnia, often accompanied by sleep-disordered breathing such as obstructive sleep apnea. The syndrome is clinically significant because it causes pulmonary hypertension, right heart failure, and increased mortality if untreated. The pathophysiology involves blunted ventilatory drive and respiratory muscle inefficiency. Diagnosis requires exclusion of other causes of hypoventilation such as neuromuscular disease or severe lung disease.

Inciting Event

Locked content

Latency Period

Locked content

Diagnostic Delay

Locked content

Clinical Presentation


Signs & Symptoms

Locked content

History of Present Illness

Locked content

Past Medical History

Locked content

Family History

Locked content

Physical Exam Findings

Locked content

Diagnostic Workup


Diagnostic Criteria

Locked content

Pathophysiology


Key Mechanisms

Locked content

Organs

Locked content

Tissues

Locked content

Cells

Locked content

Chemical Mediators

Locked content

Treatments


Pharmacological Treatments

Locked content

Non-pharmacological Treatments

Locked content

Prevention


Pharmacological Prevention

Locked content

Non-pharmacological Prevention

Locked content

Outcome & Complications


Complications

Locked content

Short-term Sequelae

Locked content

Long-term Sequelae

Locked content

Differential Diagnoses


Differentials

Locked content

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.